Increased pulse pressure linked to dementia: Further results from the Hypertension in the Very Elderly Trial - HYVET

Journal of Hypertension

Volumn 31, Issue 9, 2013, Pages 1868-1875

  Peters, Ruth ^a   Beckett, Nigel ^a   Fagard, Robert ^b   Thijs, Lutgarde ^b   Wang, Ji Guang ^c   Forette, Francoise ^d   Pereira, Lisa ^a   Fletcher, Astrid ^e   Bulpitt, Christopher ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b Hypertension and Cardiovascular Rehabilitation Unit   (Belgium)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d Paris Descartes University   (France)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Aged; Antihypertensives; Blood pressure; Dementia; Hypertension

Indexed keywords

INDAPAMIDE; PERINDOPRIL;

AGED; ARTICLE; COGNITION; DEMENTIA; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; VERY ELDERLY;

AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; COGNITION; DEMENTIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERTENSION; INDAPAMIDE; MALE; PERINDOPRIL; PROPORTIONAL HAZARDS MODELS; PULSATILE FLOW; REGRESSION ANALYSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84884201926     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283622cc6     Document Type: Article

References (32)

1. Frohlich E. Reappearance of the J-shaped curve. Hypertension 1999; 34:1179-1181.
2. Rosendorff C. The J-point revisited. Hypertension 2008; 51:e34.
3. Williams B. Hypertension. and the 'J-Curve'. J Am Coll Cardiol 2009; 54:1835-1836.
4. Zanchetti A. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. Eur Heart J 2010; 31:2837-2840.
5. Bulpitt C, Palmer A, Fletcher A., Beevers G, Coles E, Ledingham J., et al. Optimal blood pressure control in treated hypertensive patients. Report from the Department of Health Hypertension Care Computing Project (DHCCP). Circulation 1994; 90:225-233.
6. Fletcher A, Bulpitt C. How far should blood pressure be lowered? N Engl J Med 1992; 326:251-254.
7. JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res 2008; 31:2115-2127.
8. Rakugi H, Ogihara T, Goto Y., Ishii M, on behalf of the JATOS study group. Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS. Hypertens Res 2010; 33:1124-1128.
9. Hansson L, Zanchetti A, Carruthers G., Dahlöf B, Elmfeldt D., Julius S, et al, for the HOT study group. Effects of intensive blood-pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-1762.
10. Ogihara T, Saruta T, Rakugi H., Matsuoka H, Shimamato K, Shimada K., et al, Valsartin in Elderly Isolated Systolic Hypertension Study Group. Treatment of Isolated Systolic Hypertension in the Elderly Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension 2010; 56:196-202.
11. Maule S, Caserta M, Bertello C., Verhovez A, Naso D, Bisbocci Veglio F. Cognitive decline and low blood pressure: the other side of the coin. Clin Expl Hypertens 2008; 30:711-719.
12. Tzourio C, Dufouil C, Ducimetière P, Alpérovitch A, for the EVA study group. Cognitive decline in individuals with high blood pressure: A longitudinal study in the elderly. Neurology 1999; 53:1948-1952.
13. Skoog I, Lernfelt B, Landahl S., Palmertz B, Andreasson LA, Nilsson L, et al. 15 year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
14. Launer L, Masaki K, Petrovitch H., Foley D, Havlik R. The association between midlife blood pressure levels and late-life cognitive function. JAMA 1995; 274:1846-1851.
15. Elias M, Wolf P, D'Agostino R, Cobb J, White L. Untreated blood pressure level is inversely related to cognitive functioning: The Framingham study. Am J Epidemiol 1993; 138:353-364.
16. Kilander L, Nyman H, Boberg M., Hansson L, Lithell H. Hypertension is related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension 1998; 31:780-786.
17. Euser S, Bemmel T, Schram M., Gussekloo J, Hofman A, Westendorp R., Breteler M. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc 2009; 57:1223-1237.
18. Kennelly S, Lawlor B, Kenny R. Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev 2009; 8:61-70.
19. Waldstein S, Lefkowitz D, Siegel E., Rosenberger W, Spencer R, Tankard C., et al. Reduced cerebral blood flow in older men with higher levels of blood pressure. J Hypertens 2010; 28:993-998.
20. Yam A, Lang E, Lagopoulos J., Yip K, Griffith J, Mudaliar Y., Dorsch N. Cerebral autoregulation and ageing. J Clin Neurosc 2005; 12:643-645.
21. Moretti R, Torre P, Antonello R., Manganaro D, Vilotti C, Pizzolato G. Risk factors for vascular dementia: hypotension as a key point. Vasc Health Risk Manag 2008; 4:395-402.
22. Heijer T, Skoog I, Oudkerk M., Leeuw F, Groot J, Hofman A., Breteler M. Association between blood pressure levels over time and brain atrophy in the elderly. Neurobiol Aging 2003; 24:307-313.
23. Mitchell G. Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J App Physiol 2008; 105:1652-1660.
24. Verghese J, Lipton R, Hall C., Kuslansky G, Katz M. Low blood pressure and the risk of dementia in very old individuals. Neurol 2003; 61:1667-1672.
25. Leeuw F, Groot J, Oudkerk M., Witteman J, Hofman A, Gijn J., Breteler M. A follow up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999; 46:827-833.
26. Heijer T, Launer L, Prins N., Dijk E, Vermeer S, Hofman A., et al. Assocation between blood pressure white matter lesions and atrophy of the medial temporal lobe. Neurol 2005; 64:263-267.
27. Beckett NS, Peters R, Fletcher A.E., Staessen JA, Liu LS, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358:1887-1898.
28. Peters R, Beckett N, Forette F., Tuomilehto J, Clarke R, Ritchie C., et al, for the HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7:683-689.
29. Bulpitt C, Fletcher A, Beckett N., Coope J, Gil-Extremera B, Forette F, et al. Hypertension in the Very Elderly Trial (HYVET): protocol for the main trial. Drugs Aging 2001; 18:151-164.
30. Sleight P, Redon J, Verdecchia P., Mancia M, Gao P, Fagard R., et al, on behalf of the ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the ongoing telmisartin alone and in combination with ramipril global endpoint trial study. J Hypertens 2009; 27:1360-1369.
31. American Psychiatric Assn WDU. Diagnostic and statistical manual of mental disorders, (4th ed.) Washington, DC: American Psychiatric Publishing, Inc; 1994.
32. Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, et al. Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637.